Deutsche Bank Ag\ Celcuity Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Celcuity Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 13,668 shares of CELC stock, worth $171,533. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,668

Previous 9,785 39.68%

Holding current value

$171,533

Previous $160,000 26.88%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$13.98 - $19.15 $54,284 - $74,359	3,883 Added 39.68%	13,668 $203,000
Q2 2024 Aug 14, 2024	BUY	$14.1 - $20.78 $13,719 - $20,218	973 Added 11.04%	9,785 $160,000
Q1 2024 May 15, 2024	BUY	$13.74 - $21.6 $4,286 - $6,739	312 Added 3.67%	8,812 $190,000
Q4 2023 Feb 14, 2024	BUY	$8.7 - $15.02 $2,479 - $4,280	285 Added 3.47%	8,500 $123,000
Q3 2023 Nov 09, 2023	BUY	$8.96 - $10.75 $73,606 - $88,311	8,215 New	8,215 $75,000
Q2 2022 Aug 11, 2022	SELL	$5.35 - $10.11 $28,189 - $53,269	-5,269 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$7.93 - $13.33 $4,916 - $8,264	-620 Reduced 10.53%	5,269 $49,000
Q4 2021 Feb 11, 2022	BUY	$11.96 - $19.35 $3,707 - $5,998	310 Added 5.56%	5,889 $77,000
Q3 2021 Nov 04, 2021	BUY	$17.35 - $24.87 $14,400 - $20,642	830 Added 17.48%	5,579 $100,000
Q2 2021 Aug 11, 2021	BUY	$14.25 - $30.93 $67,673 - $146,886	4,749 New	4,749 $114,000
Q3 2020 Nov 12, 2020	SELL	$5.1 - $7.07 $1,019 - $1,414	-200 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$4.42 - $11.04 $12,999 - $32,468	-2,941 Reduced 93.63%	200 $1,000
Q1 2020 May 14, 2020	BUY	$5.79 - $11.78 $81 - $164	14 Added 0.45%	3,141 $20,000
Q4 2019 Feb 14, 2020	BUY	$9.47 - $16.71 $13,485 - $23,795	1,424 Added 83.62%	3,127 $31,000
Q3 2019 Nov 14, 2019	SELL	$15.74 - $23.65 $45,488 - $68,348	-2,890 Reduced 62.92%	1,703 $28,000
Q2 2019 Aug 14, 2019	SELL	$19.88 - $25.0 $88,525 - $111,325	-4,453 Reduced 49.23%	4,593 $112,000
Q1 2019 May 15, 2019	BUY	$18.38 - $24.44 $26,283 - $34,949	1,430 Added 18.78%	9,046 $197,000
Q4 2018 Feb 14, 2019	SELL	$20.87 - $29.05 $307,895 - $428,574	-14,753 Reduced 65.95%	7,616 $182,000
Q3 2018 Dec 21, 2021	BUY	$20.96 - $30.77 $31,984 - $46,955	1,526 Added 7.32%	22,369 $643,000
Q3 2018 Nov 14, 2018	BUY	$20.96 - $30.77 $203,542 - $298,807	9,711 Added 87.23%	20,843 $598,000
Q2 2018 Apr 21, 2020	BUY	$16.13 - $26.99 $30,437 - $50,930	1,887 Added 20.41%	11,132 $276,000
Q2 2018 Aug 14, 2018	BUY	$16.13 - $26.99 $90,489 - $151,413	5,610 Added 154.33%	9,245 $229,000
Q1 2018 Oct 18, 2019	BUY	$13.55 - $21.3 $8,658 - $13,610	639 Added 21.33%	3,635 $59,000
Q1 2018 May 15, 2018	SELL	$13.55 - $21.3 $42,872 - $67,393	-3,164 Reduced 51.36%	2,996 $49,000
Q4 2017 Feb 14, 2018	BUY	$12.12 - $21.65 $74,659 - $133,364	6,160	6,160 $116,000

Others Institutions Holding CELC

# of Institutions

107

Shares Held

30.3M

Call Options Held

30.8K

Put Options Held

152K

View Full List

About Celcuity Inc.

Ticker CELC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,941,300
Market Cap $188M
Description
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...

More about CELC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account